Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation
Marshall R. Posner(Icahn School of Medicine at Mount Sinai), Robert I. Haddad(Georgetown University), Sergei Tjulandin, C. Blajman, Gary Frenette, Julian Freue(Hospital Zonal General De Agudos Descentralizado "Evita Pueblo"), Lori J. Wirth(Massachusetts General Hospital), E. Mickiewicz, Eric Winquist(Western University), L.F. Plinar(University Hospital, Newark), Lynn M. Steinbrenner(VA Western New York Healthcare System), Martin Roessner(Sanofi (United States)), Vera Gorbunova(University of Rochester), Douglas R. Adkins(Washington University in St. Louis), Charles M. Norris, Roy B. Tishler(Dana-Farber Cancer Institute), Roger B. Cohen(University of Pennsylvania), Dong M. Shin(Emory University), Kevin J. Cullen(University of Maryland, Baltimore), Luis E. Raez(Florida International University)
Cited by 152
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k